Organ Dysfunction
8
2
2
2
Key Insights
Highlights
Success Rate
67% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
12.5%
1 terminated out of 8 trials
66.7%
-19.8% vs benchmark
25%
2 trials in Phase 3/4
0%
0 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (8)
Organ Dysfunction Score for Obstetric Patients
Validation of SOFA-2 for Mortality and Sepsis-3 Prevalence in Turkey
The Effect of the Timing of Supplemental Parenteral Nutrition on the Prognosis of Critically Ill Patients (T-SPN)
ICU Background Early Awareness for Critical deterioratiON
Glucocorticoids for Post-operative Patients With Acute Type A Aortic Dissection (The GLAD Trial)
Evaluation of Toxicity From Stem Cell Transplant
Pharmacology of Exenatide in Pediatric Sepsis
Intraoperative Hypovolemia and Fluid Therapy